Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,052
archived clinical trials in
Nephrology

Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated:  12/31/1969
Abbott Northwestern
623
mi
from 43215
Minneapolis, MN
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated: 12/31/1969
Abbott Northwestern
623
mi
from 43215
Minneapolis, MN
Click here to add this to my saved trials
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated:  12/31/1969
North Mississippi Medical Center
506
mi
from 43215
Tupelo, MS
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated: 12/31/1969
North Mississippi Medical Center
506
mi
from 43215
Tupelo, MS
Click here to add this to my saved trials
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated:  12/31/1969
St. Joseph Medical Center
406
mi
from 43215
Saint Charles, MO
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated: 12/31/1969
St. Joseph Medical Center
406
mi
from 43215
Saint Charles, MO
Click here to add this to my saved trials
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated:  12/31/1969
Mount Sinai Hospital
480
mi
from 43215
New York, NY
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated: 12/31/1969
Mount Sinai Hospital
480
mi
from 43215
New York, NY
Click here to add this to my saved trials
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated:  12/31/1969
Austin Heart Central
1063
mi
from 43215
Austin, TX
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated: 12/31/1969
Austin Heart Central
1063
mi
from 43215
Austin, TX
Click here to add this to my saved trials
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated:  12/31/1969
Baylor Scott & White
901
mi
from 43215
Plano, TX
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated: 12/31/1969
Baylor Scott & White
901
mi
from 43215
Plano, TX
Click here to add this to my saved trials
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated:  12/31/1969
Austin Heart Round Rock
1053
mi
from 43215
Round Rock, TX
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated: 12/31/1969
Austin Heart Round Rock
1053
mi
from 43215
Round Rock, TX
Click here to add this to my saved trials
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated:  12/31/1969
MedStar Washington Hospital Center
328
mi
from 43215
Washington,
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated: 12/31/1969
MedStar Washington Hospital Center
328
mi
from 43215
Washington,
Click here to add this to my saved trials
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated:  12/31/1969
Montefiore Medical Center
485
mi
from 43215
New York, NY
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated: 12/31/1969
Montefiore Medical Center
485
mi
from 43215
New York, NY
Click here to add this to my saved trials
A Pilot Study to Assess the Efficacy of Rituximab Therapy in Treatment Resistant FSGS
A Pilot Study to Assess the Efficacy of Rituximab Therapy in Patients With Treatment Resistant Idiopathic Focal Segmental Glomerulosclerosis (FSGS): Integrating an Assessment of the Relevance of suPAR and Activation of Podocyte β3 Integrin
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic College of Medicine
559
mi
from 43215
Rochester, MN
A Pilot Study to Assess the Efficacy of Rituximab Therapy in Treatment Resistant FSGS
A Pilot Study to Assess the Efficacy of Rituximab Therapy in Patients With Treatment Resistant Idiopathic Focal Segmental Glomerulosclerosis (FSGS): Integrating an Assessment of the Relevance of suPAR and Activation of Podocyte β3 Integrin
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic College of Medicine
559
mi
from 43215
Rochester, MN
Click here to add this to my saved trials
A Pilot Study to Assess the Efficacy of Rituximab Therapy in Treatment Resistant FSGS
A Pilot Study to Assess the Efficacy of Rituximab Therapy in Patients With Treatment Resistant Idiopathic Focal Segmental Glomerulosclerosis (FSGS): Integrating an Assessment of the Relevance of suPAR and Activation of Podocyte β3 Integrin
Status: Enrolling
Updated:  12/31/1969
Rush University Medical Center
277
mi
from 43215
Chicago, IL
A Pilot Study to Assess the Efficacy of Rituximab Therapy in Treatment Resistant FSGS
A Pilot Study to Assess the Efficacy of Rituximab Therapy in Patients With Treatment Resistant Idiopathic Focal Segmental Glomerulosclerosis (FSGS): Integrating an Assessment of the Relevance of suPAR and Activation of Podocyte β3 Integrin
Status: Enrolling
Updated: 12/31/1969
Rush University Medical Center
277
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
A Pilot Study to Assess the Efficacy of Rituximab Therapy in Treatment Resistant FSGS
A Pilot Study to Assess the Efficacy of Rituximab Therapy in Patients With Treatment Resistant Idiopathic Focal Segmental Glomerulosclerosis (FSGS): Integrating an Assessment of the Relevance of suPAR and Activation of Podocyte β3 Integrin
Status: Enrolling
Updated:  12/31/1969
New York Univ. Medical Center
477
mi
from 43215
New York, NY
A Pilot Study to Assess the Efficacy of Rituximab Therapy in Treatment Resistant FSGS
A Pilot Study to Assess the Efficacy of Rituximab Therapy in Patients With Treatment Resistant Idiopathic Focal Segmental Glomerulosclerosis (FSGS): Integrating an Assessment of the Relevance of suPAR and Activation of Podocyte β3 Integrin
Status: Enrolling
Updated: 12/31/1969
New York Univ. Medical Center
477
mi
from 43215
New York, NY
Click here to add this to my saved trials
A Pilot Study to Assess the Efficacy of Rituximab Therapy in Treatment Resistant FSGS
A Pilot Study to Assess the Efficacy of Rituximab Therapy in Patients With Treatment Resistant Idiopathic Focal Segmental Glomerulosclerosis (FSGS): Integrating an Assessment of the Relevance of suPAR and Activation of Podocyte β3 Integrin
Status: Enrolling
Updated:  12/31/1969
Sunnybrook Health Sciences Centre
316
mi
from 43215
Toronto,
A Pilot Study to Assess the Efficacy of Rituximab Therapy in Treatment Resistant FSGS
A Pilot Study to Assess the Efficacy of Rituximab Therapy in Patients With Treatment Resistant Idiopathic Focal Segmental Glomerulosclerosis (FSGS): Integrating an Assessment of the Relevance of suPAR and Activation of Podocyte β3 Integrin
Status: Enrolling
Updated: 12/31/1969
Sunnybrook Health Sciences Centre
316
mi
from 43215
Toronto,
Click here to add this to my saved trials
A Pilot Study to Assess the Efficacy of Rituximab Therapy in Treatment Resistant FSGS
A Pilot Study to Assess the Efficacy of Rituximab Therapy in Patients With Treatment Resistant Idiopathic Focal Segmental Glomerulosclerosis (FSGS): Integrating an Assessment of the Relevance of suPAR and Activation of Podocyte β3 Integrin
Status: Enrolling
Updated:  12/31/1969
Albert Einstein College of Medicine (The Children's Hospital at Monteflore)
486
mi
from 43215
Bronx, NY
A Pilot Study to Assess the Efficacy of Rituximab Therapy in Treatment Resistant FSGS
A Pilot Study to Assess the Efficacy of Rituximab Therapy in Patients With Treatment Resistant Idiopathic Focal Segmental Glomerulosclerosis (FSGS): Integrating an Assessment of the Relevance of suPAR and Activation of Podocyte β3 Integrin
Status: Enrolling
Updated: 12/31/1969
Albert Einstein College of Medicine (The Children's Hospital at Monteflore)
486
mi
from 43215
Bronx, NY
Click here to add this to my saved trials
"Dusting" Versus "Basketing" - Treatment Of Intrarenal Stones
Ureteroscopic Treatment of Intrarenal Stones - A Comparative Analysis of "Dusting" Versus "Basketing" With Holmium Laser Lithotripsy
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic
1644
mi
from 43215
Scottsdale, AZ
"Dusting" Versus "Basketing" - Treatment Of Intrarenal Stones
Ureteroscopic Treatment of Intrarenal Stones - A Comparative Analysis of "Dusting" Versus "Basketing" With Holmium Laser Lithotripsy
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic
1644
mi
from 43215
Scottsdale, AZ
Click here to add this to my saved trials
"Dusting" Versus "Basketing" - Treatment Of Intrarenal Stones
Ureteroscopic Treatment of Intrarenal Stones - A Comparative Analysis of "Dusting" Versus "Basketing" With Holmium Laser Lithotripsy
Status: Enrolling
Updated:  12/31/1969
UCSD
1951
mi
from 43215
San Diego, CA
"Dusting" Versus "Basketing" - Treatment Of Intrarenal Stones
Ureteroscopic Treatment of Intrarenal Stones - A Comparative Analysis of "Dusting" Versus "Basketing" With Holmium Laser Lithotripsy
Status: Enrolling
Updated: 12/31/1969
UCSD
1951
mi
from 43215
San Diego, CA
Click here to add this to my saved trials
"Dusting" Versus "Basketing" - Treatment Of Intrarenal Stones
Ureteroscopic Treatment of Intrarenal Stones - A Comparative Analysis of "Dusting" Versus "Basketing" With Holmium Laser Lithotripsy
Status: Enrolling
Updated:  12/31/1969
James Buchanan Brady Urological Institute
344
mi
from 43215
Baltimore, MD
"Dusting" Versus "Basketing" - Treatment Of Intrarenal Stones
Ureteroscopic Treatment of Intrarenal Stones - A Comparative Analysis of "Dusting" Versus "Basketing" With Holmium Laser Lithotripsy
Status: Enrolling
Updated: 12/31/1969
James Buchanan Brady Urological Institute
344
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
"Dusting" Versus "Basketing" - Treatment Of Intrarenal Stones
Ureteroscopic Treatment of Intrarenal Stones - A Comparative Analysis of "Dusting" Versus "Basketing" With Holmium Laser Lithotripsy
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital
643
mi
from 43215
Boston, MA
"Dusting" Versus "Basketing" - Treatment Of Intrarenal Stones
Ureteroscopic Treatment of Intrarenal Stones - A Comparative Analysis of "Dusting" Versus "Basketing" With Holmium Laser Lithotripsy
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
"Dusting" Versus "Basketing" - Treatment Of Intrarenal Stones
Ureteroscopic Treatment of Intrarenal Stones - A Comparative Analysis of "Dusting" Versus "Basketing" With Holmium Laser Lithotripsy
Status: Enrolling
Updated:  12/31/1969
Bellevue Hospital
479
mi
from 43215
New York, NY
"Dusting" Versus "Basketing" - Treatment Of Intrarenal Stones
Ureteroscopic Treatment of Intrarenal Stones - A Comparative Analysis of "Dusting" Versus "Basketing" With Holmium Laser Lithotripsy
Status: Enrolling
Updated: 12/31/1969
Bellevue Hospital
479
mi
from 43215
New York, NY
Click here to add this to my saved trials
"Dusting" Versus "Basketing" - Treatment Of Intrarenal Stones
Ureteroscopic Treatment of Intrarenal Stones - A Comparative Analysis of "Dusting" Versus "Basketing" With Holmium Laser Lithotripsy
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic
129
mi
from 43215
Cleveland, OH
"Dusting" Versus "Basketing" - Treatment Of Intrarenal Stones
Ureteroscopic Treatment of Intrarenal Stones - A Comparative Analysis of "Dusting" Versus "Basketing" With Holmium Laser Lithotripsy
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic
129
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
"Dusting" Versus "Basketing" - Treatment Of Intrarenal Stones
Ureteroscopic Treatment of Intrarenal Stones - A Comparative Analysis of "Dusting" Versus "Basketing" With Holmium Laser Lithotripsy
Status: Enrolling
Updated:  12/31/1969
Ohio State University
2
mi
from 43215
Columbus, OH
"Dusting" Versus "Basketing" - Treatment Of Intrarenal Stones
Ureteroscopic Treatment of Intrarenal Stones - A Comparative Analysis of "Dusting" Versus "Basketing" With Holmium Laser Lithotripsy
Status: Enrolling
Updated: 12/31/1969
Ohio State University
2
mi
from 43215
Columbus, OH
Click here to add this to my saved trials
"Dusting" Versus "Basketing" - Treatment Of Intrarenal Stones
Ureteroscopic Treatment of Intrarenal Stones - A Comparative Analysis of "Dusting" Versus "Basketing" With Holmium Laser Lithotripsy
Status: Enrolling
Updated:  12/31/1969
Vanderbilt University School of Medicine
331
mi
from 43215
Nashville, TN
"Dusting" Versus "Basketing" - Treatment Of Intrarenal Stones
Ureteroscopic Treatment of Intrarenal Stones - A Comparative Analysis of "Dusting" Versus "Basketing" With Holmium Laser Lithotripsy
Status: Enrolling
Updated: 12/31/1969
Vanderbilt University School of Medicine
331
mi
from 43215
Nashville, TN
Click here to add this to my saved trials
"Dusting" Versus "Basketing" - Treatment Of Intrarenal Stones
Ureteroscopic Treatment of Intrarenal Stones - A Comparative Analysis of "Dusting" Versus "Basketing" With Holmium Laser Lithotripsy
Status: Enrolling
Updated:  12/31/1969
University of British Columbia
2051
mi
from 43215
Vancouver,
"Dusting" Versus "Basketing" - Treatment Of Intrarenal Stones
Ureteroscopic Treatment of Intrarenal Stones - A Comparative Analysis of "Dusting" Versus "Basketing" With Holmium Laser Lithotripsy
Status: Enrolling
Updated: 12/31/1969
University of British Columbia
2051
mi
from 43215
Vancouver,
Click here to add this to my saved trials
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
699
mi
from 43215
Mobile, AL
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
699
mi
from 43215
Mobile, AL
Click here to add this to my saved trials
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
1658
mi
from 43215
Tempe, AZ
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1658
mi
from 43215
Tempe, AZ
Click here to add this to my saved trials
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
1950
mi
from 43215
La Jolla, CA
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1950
mi
from 43215
La Jolla, CA
Click here to add this to my saved trials
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
1967
mi
from 43215
La Palma, CA
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1967
mi
from 43215
La Palma, CA
Click here to add this to my saved trials
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
1983
mi
from 43215
Los Angeles, CA
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1983
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
1983
mi
from 43215
Los Angeles, CA
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1983
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
2093
mi
from 43215
San Leandro, CA
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
2093
mi
from 43215
San Leandro, CA
Click here to add this to my saved trials
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
1980
mi
from 43215
Torrance, CA
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1980
mi
from 43215
Torrance, CA
Click here to add this to my saved trials
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
992
mi
from 43215
Miami, FL
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
992
mi
from 43215
Miami, FL
Click here to add this to my saved trials
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
343
mi
from 43215
Baltimore, MD
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
343
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
165
mi
from 43215
Ann Arbor, MI
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
165
mi
from 43215
Ann Arbor, MI
Click here to add this to my saved trials
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
478
mi
from 43215
Brooklyn, NY
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
478
mi
from 43215
Brooklyn, NY
Click here to add this to my saved trials
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
487
mi
from 43215
Flushing, NY
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
487
mi
from 43215
Flushing, NY
Click here to add this to my saved trials
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
492
mi
from 43215
Great Neck, NY
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
492
mi
from 43215
Great Neck, NY
Click here to add this to my saved trials
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
493
mi
from 43215
Manhasset, NY
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
493
mi
from 43215
Manhasset, NY
Click here to add this to my saved trials
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
481
mi
from 43215
New York, NY
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
481
mi
from 43215
New York, NY
Click here to add this to my saved trials
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
481
mi
from 43215
New York, NY
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
481
mi
from 43215
New York, NY
Click here to add this to my saved trials
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
353
mi
from 43215
Chapel Hill, NC
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
353
mi
from 43215
Chapel Hill, NC
Click here to add this to my saved trials
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
366
mi
from 43215
Raleigh, NC
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
366
mi
from 43215
Raleigh, NC
Click here to add this to my saved trials
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
7
mi
from 43215
Columbus, OH
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
7
mi
from 43215
Columbus, OH
Click here to add this to my saved trials
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
400
mi
from 43215
Bethlehem, PA
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
400
mi
from 43215
Bethlehem, PA
Click here to add this to my saved trials
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
414
mi
from 43215
Philadelphia, PA
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
414
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
414
mi
from 43215
Philadelphia, PA
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
414
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
524
mi
from 43215
Charleston, SC
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
524
mi
from 43215
Charleston, SC
Click here to add this to my saved trials
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
892
mi
from 43215
Allentown, TX
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
892
mi
from 43215
Allentown, TX
Click here to add this to my saved trials
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
1064
mi
from 43215
Austin, TX
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1064
mi
from 43215
Austin, TX
Click here to add this to my saved trials
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
905
mi
from 43215
Dallas, TX
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
905
mi
from 43215
Dallas, TX
Click here to add this to my saved trials